Clinical Trial Update: Ultralow Dose PET Imaging for PSMA Expression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ultralow-dose PSMA PET imaging for detecting PSMA expression in healthy volunteers and men with prostate cancer; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Akiva Mintz | Conditions: Healthy Volunteer, Prostate CA | Phase 2 | Status: RECRUITING